drugset / Trial / NCT00877539
A Study To Assess The Effect Of PF-03526299 On Lung Function Following An Allergen Challenge In Asthmatic Subjects
RandomizedCrossoverDouble-blindTreatment
Summary
PF-03526299, a novel anti-inflammatory agent should attenuate the effect of a bronchial allergen challenge on lung function and hence provide proof of mechanism for this agent.
Timeline
- Start
- 2009-06
- Primary completion
- 2009-12
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fluticasone propionate | Other / unclassified | — | Inhaled |
| Subject | PF-03526299 | Unknown | — | Inhaled |